Non–Small Cell Lung Cancer, Version 4.2024
Journal of the National Comprehensive Cancer Network · 2024-05 · 22 (4) · 249-274
DOI: 10.6004/jnccn.2204.0023 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-05. Verfasst von Gregory J Riely und 44 weiteren Autor:innen. Beteiligte Einrichtung: 1Memorial Sloan Kettering Cancer Center. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 839-mal zitiert (Crossref) und nennt 234 Literaturangaben.
Abstract (Originalsprache)
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance for relapse, and subsequent treatment. The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable molecular biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1Memorial Sloan Kettering Cancer Center.
- 2Fred Hutchinson Cancer Center.
- 3The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- 4University of Colorado Cancer Center.
- 5Huntsman Cancer Institute at the University of Utah.
- 6Fox Chase Cancer Center.
Zitieren
APA
Riely, G. J., Wood, D. E., Ettinger, D. S., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Desai, A. P., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Juloori, A., …, & Hang, L. (2024). Non–Small Cell Lung Cancer, Version 4.2024. Journal of the National Comprehensive Cancer Network, 22(4), 249-274. https://doi.org/10.6004/jnccn.2204.0023
Vancouver
Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, et al. Non–Small Cell Lung Cancer, Version 4.2024. Journal of the National Comprehensive Cancer Network. 2024;22(4):249-274. doi:10.6004/jnccn.2204.0023
BibTeX
@article{Riely2024,
author = {Riely, Gregory J and Wood, Douglas E and Ettinger, David S and Aisner, Dara L and Akerley, Wallace and Bauman, Jessica R and Bharat, Ankit and Bruno, Debora S and Chang, Joe Y and Chirieac, Lucian R and DeCamp, Malcolm and Desai, Aakash P and Dilling, Thomas J and Dowell, Jonathan and Durm, Gregory A and Gettinger, Scott and Grotz, Travis E and Gubens, Matthew A and Juloori, Aditya and Lackner, Rudy P and Lanuti, Michael and Lin, Jules and Loo, Billy W and Lovly, Christine M and Maldonado, Fabien and Massarelli, Erminia and Morgensztern, Daniel and Mullikin, Trey C and Ng, Thomas and Owen, Dawn and Owen, Dwight H and Patel, Sandip P and Patil, Tejas and Polanco, Patricio M and Riess, Jonathan and Shapiro, Theresa A and Singh, Aditi P and Stevenson, James and Tam, Alda and Tanvetyanon, Tawee and Yanagawa, Jane and Yang, Stephen C and Yau, Edwin and Gregory, Kristina M and Hang, Lisa},
title = {Non–Small Cell Lung Cancer, Version 4.2024},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {4},
pages = {249--274},
doi = {10.6004/jnccn.2204.0023}
}
EUVIMED